just replying to myself & my incorrect math... inavir's infection rate is actually 4.9% (not 3.6%) compared to relenza's 4%.
4.9% vs 8.5% placebo = about 42% & a bit
using relenza's 19% placebo rate, the reduction would equate to 4.9% vs 19% placebo = 74% (not 81%)